Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DERM

Dermira

$23.82

-0.97 (-3.91%)

, EBIO

Eleven Biotherapeutics

$0.69

0.006 (0.88%)

04:55
11/15/17
11/15
04:55
11/15/17
04:55
Conference/Events
Stifel to hold a conference »

Healthcare Conference is…

DERM

Dermira

$23.82

-0.97 (-3.91%)

EBIO

Eleven Biotherapeutics

$0.69

0.006 (0.88%)

ACOR

Acorda Therapeutics

$28.20

0.5 (1.81%)

LOXO

Loxo Oncology

$79.84

-3.39 (-4.07%)

CELG

Celgene

$98.86

-2.3 (-2.27%)

INSM

Insmed

$30.06

-1.72 (-5.41%)

SUPN

Supernus

$37.20

-0.6 (-1.59%)

HZNP

Horizon Pharma

$13.07

-0.35 (-2.61%)

IRIX

IRIDEX

$8.01

-0.14 (-1.72%)

MASI

Masimo

$86.43

0.75 (0.88%)

BMRN

BioMarin

$81.41

0.35 (0.43%)

OVID

Ovid Therapeutics

$9.44

-0.22 (-2.28%)

MD

Mednax

$46.32

0.9 (1.98%)

JNCE

Jounce Therapeutics

$14.13

-0.68 (-4.59%)

KIDS

OrthoPediatrics

$19.18

-0.92 (-4.58%)

XON

Intrexon

$12.68

0.1 (0.79%)

CARA

Cara Therapeutics

$12.08

-0.85 (-6.57%)

HOLX

Hologic

$39.62

-1.02 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 29

    Nov

  • 29

    Nov

  • 30

    Nov

  • 01

    Dec

  • 05

    Dec

  • 14

    Dec

  • 28

    Feb

  • 30

    Jun

Over a week ago
DERM

Dermira

$24.79

-0.02 (-0.08%)

, EBIO

Eleven Biotherapeutics

$0.68

0.0032 (0.47%)

07:20
11/14/17
11/14
07:20
11/14/17
07:20
Conference/Events
Stifel to hold a conference »

Healthcare Conference is…

DERM

Dermira

$24.79

-0.02 (-0.08%)

EBIO

Eleven Biotherapeutics

$0.68

0.0032 (0.47%)

ACOR

Acorda Therapeutics

$27.70

-0.25 (-0.89%)

LOXO

Loxo Oncology

$83.23

2.05 (2.53%)

CELG

Celgene

$101.16

-1.18 (-1.15%)

INSM

Insmed

$31.78

0.96 (3.11%)

SUPN

Supernus

$37.80

0.55 (1.48%)

HZNP

Horizon Pharma

$13.42

-0.15 (-1.11%)

IRIX

IRIDEX

$8.15

0.03 (0.37%)

MASI

Masimo

$85.68

-0.81 (-0.94%)

BMRN

BioMarin

$81.06

-0.97 (-1.18%)

OVID

Ovid Therapeutics

$9.66

0.63 (6.98%)

MD

Mednax

$45.42

0.95 (2.14%)

JNCE

Jounce Therapeutics

$14.81

0.04 (0.27%)

KIDS

OrthoPediatrics

$20.10

0.35 (1.77%)

XON

Intrexon

$12.58

0.77 (6.52%)

CARA

Cara Therapeutics

$12.93

-0.33 (-2.49%)

HOLX

Hologic

$40.64

1.67 (4.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 29

    Nov

  • 29

    Nov

  • 30

    Nov

  • 01

    Dec

  • 05

    Dec

  • 14

    Dec

  • 28

    Feb

  • 30

    Jun

SUPN

Supernus

$36.40

-4.7 (-11.44%)

06:02
11/08/17
11/08
06:02
11/08/17
06:02
Upgrade
Supernus rating change at Stifel »

Supernus upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 28

    Nov

SUPN

Supernus

$36.40

-4.7 (-11.44%)

19:25
11/07/17
11/07
19:25
11/07/17
19:25
Upgrade
Supernus rating change at Stifel »

Supernus upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

  • 28

    Nov

SUPN

Supernus

$41.10

-0.95 (-2.26%)

11:23
11/07/17
11/07
11:23
11/07/17
11:23
Recommendations
Supernus analyst commentary at SunTrust »

Supernus should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

  • 28

    Nov

SUPN

Supernus

$41.10

-0.95 (-2.26%)

17:07
11/06/17
11/06
17:07
11/06/17
17:07
Hot Stocks
Supernus raises FY17 net product sales $290M-$295M from $280M-$290M »

Raises FY17 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

  • 28

    Nov

SUPN

Supernus

$41.10

-0.95 (-2.26%)

17:05
11/06/17
11/06
17:05
11/06/17
17:05
Earnings
Supernus reports Q3 EPS 29c, consensus 27c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

  • 28

    Nov

Over a month ago
SUPN

Supernus

$41.25

0.2 (0.49%)

07:16
10/19/17
10/19
07:16
10/19/17
07:16
Initiation
Supernus initiated at FBR Capital »

FBR sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUPN

Supernus

$41.25

0.2 (0.49%)

05:38
10/19/17
10/19
05:38
10/19/17
05:38
Initiation
Supernus initiated at FBR Capital »

Supernus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUPN

Supernus

$39.10

0.1 (0.26%)

06:17
09/26/17
09/26
06:17
09/26/17
06:17
Recommendations
Supernus analyst commentary at Piper Jaffray »

Supernus not cheap even…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.